Pilot study of interferon gamma for chronic hepatitis C

Journal of Hepatology

Volumn 43, Issue 1, 2005, Pages 67-71

  Soza, Alejandro ^a   Heller, Theo ^a   Ghany, Marc ^a   Lutchman, Glen ^a   Liang, T Jake ^a   Germain, June ^b   Hsu, Henry H ^c   Park, Yoon ^a   Hoofnagle, Jay H ^a,d  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c InterMune Inc   (United States)

^d NONE   (United States)

Author keywords

Antiviral therapy; Bone marrow suppression; Cytokines; Interferon alfa; Interferon gamma; Viral kinetics

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; GAMMA1B INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; GENOTYPE; HEPATITIS C; HUMAN; MALAISE; MALE; MYALGIA; NAUSEA; NEUTROPHIL; PILOT STUDY; PRIORITY JOURNAL; RELAPSE; RNA VIRUS;

ANTIVIRAL AGENTS; BLOOD CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; MALE; MIDDLE AGED; PILOT PROJECTS; RECURRENCE; RIBAVIRIN; RNA, VIRAL; TRANSAMINASES; TREATMENT FAILURE;

EID: 20444375441     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.02.023     Document Type: Article

References (24)

1. Hepatitis C - global prevalence (update). Wkly Epidemiol Rec 1999;74:425-7.
2. WHO and the Viral Hepatitis Prevention Board. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999;6:35-47.
3. R.S. Brown Jr, and P.J. Gaglio Scope of worldwide hepatitis C problem Liver Transpl 9 2003 S10 S13
4. J.H. Hoofnagle, K.D. Mullen, D.B. Jones, V. Rustgi, A. Di Bisceglie, and M. Peters Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report N Engl J Med 315 1986 1575 1578
5. A.M. Di Bisceglie, and J.H. Hoofnagle Optimal therapy of hepatitis C Hepatology 36 2002 S121 S127
6. M. Peters Actions of cytokines on the immune response and viral interactions: an overview Hepatology 23 1996 909 916
7. M. Gale Jr Effector genes of interferon action against hepatitis C virus Hepatology 37 2003 975 978
8. I.W. Cheney, V.C. Lai, W. Zhong, T. Brodhag, S. Dempsey, and C. Lim Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons J Virol 76 2002 11148 11154
9. C.E. Samuel Antiviral actions of interferons Clin Microbiol Rev 14 2001 778 809 [table of contents]
10. R.E. Lanford, B. Guerra, H. Lee, D.R. Averett, B. Pfeiffer, and D. Chavez Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons J Virol 77 2003 1092 1104
11. M. Frese, V. Schwarzle, K. Barth, N. Krieger, V. Lohmann, and S. Mihm Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs Hepatology 35 2002 694 703
12. A.M. Di Bisceglie, V.K. Rustgi, C. Kassianides, M. Lisker-Melman, Y. Park, and J.G. Waggoner Therapy of chronic hepatitis B with recombinant human alpha and gamma interferon Hepatology 11 1990 266 270
13. S. Kakumu, T. Ishikawa, M. Mizokami, E. Orido, K. Yoshioka, and T. Wakita Treatment with human gamma interferon of chronic hepatitis B: comparative study with alpha interferon J Med Virol 35 1991 32 37
14. J.Y. Lau, C.L. Lai, P.C. Wu, H.T. Chung, A.S. Lok, and H.J. Lin A randomised controlled trial of recombinant interferon-gamma in Chinese patients with chronic hepatitis B virus infection J Med Virol 34 1991 184 187
15. P. Marcellin, M.A. Loriot, N. Boyer, M. Martinot-Peignoux, C. Degott, and F. Degos Recombinant human gamma-interferon in patients with chronic active hepatitis B: pharmacokinetics, tolerance and biological effects Hepatology 12 1990 155 158
16. F. Saez-Royuela, J.C. Porres, A. Moreno, I. Castillo, G. Martinez, and F. Galiana High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial Hepatology 13 1991 327 331
17. R. Kumashiro, T. Ide, M. Sasaki, S. Murashima, H. Suzuki, and T. Hino Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis C Hepatol Res 22 2002 20 26
18. J. Larkin, L. Jin, M. Farmen, D. Venable, Y. Huang, and S.L. Tan Synergistic antiviral activity of human interferon combinations in the hepatitis C virus replicon system J Interferon Cytokine Res 23 2003 247 257
19. C. Okuse, J.A. Rinaudo, K. Farrar, F. Wells, and B.E. Korba Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy Antiviral Res 65 2005 23 34
20. InterMune, Inc. InterMune announces results of exploratory phase II study of interferon gamma-1b in advanced liver fibrosis; 2004. www.intermune.com: Accesed Jan 2005.
21. A. Soza, J.E. Everhart, M.G. Ghany, E. Doo, T. Heller, and K. Promrat Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C Hepatology 36 2002 1273 1279
22. G. Lutchman, and J.H. Hoofnagle Viral kinetics in hepatitis C Hepatology 37 2003 1257 1259
23. P. Ferenci Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies J Antimicrob Chemother 53 2004 15 18
24. A.U. Neumann, N.P. Lam, H. Dahari, D.R. Gretch, T.E. Wiley, and T.J. Layden Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy Science 282 1998 103 107